Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver and Kidney Tumours”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT05293041
What this trial is testing

Argipressin's Influence on Blood Loss During Hepatic Resection

Who this might be right for
Colon Cancer Liver MetastasisInflammatory ResponseVasopressin Causing Adverse Effects in Therapeutic Use
Kristina Svennerholm 248
Not applicableActive Not RecruitingNCT02991105
What this trial is testing

Epidemiology of Complications After Solid Organ Transplantation - EpCOT Study

Who this might be right for
MalignancyTransplant ComplicationCancer+3 more
University of Birmingham 85,410
Early research (Phase 1)Study completedNCT00423254
What this trial is testing

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

Who this might be right for
OvarianMelanomaRenal+20 more
Mannkind Corporation 12
Not applicableStudy completedNCT04185454
What this trial is testing

Estimation of Minimum Efficacy Daily Dose of Jarlsberg Cheese

Who this might be right for
Heathy WomenPre Menopausal AgeExlution Criteria: Gastrointestinal Disorder+4 more
Prof Stig Larsen 20
Early research (Phase 1)Study completedNCT00118170
What this trial is testing

Sorafenib in Treating Patients With Metastatic or Unresectable Solid Tumors, Multiple Myeloma, or Non-Hodgkin's Lymphoma With or Without Impaired Liver or Kidney Function

Who this might be right for
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Adult Burkitt Lymphoma+42 more
National Cancer Institute (NCI) 150
Not applicableStudy completedNCT04825834
What this trial is testing

DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)

Who this might be right for
Lung CancerHead and Neck CancerEsophageal Cancer+7 more
Delfi Diagnostics Inc. 2,992
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Not applicableStudy completedNCT00428220
What this trial is testing

A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.

Who this might be right for
Metastatic Breast CancerAdvanced Breast CancerMetastatic Castration Resistant Prostate Cancer+9 more
Pfizer 223
Early research (Phase 1)Study completedNCT04430842
What this trial is testing

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Who this might be right for
AstrocytomaBrain CancerBrain Metastases+20 more
Quadriga Biosciences, Inc. 15
Not applicableStudy completedNCT05786482
What this trial is testing

Evidence Based Mental Wellness Programming Online for Adults Across Chronic Physical Conditions

Who this might be right for
Primary Biliary CholangitisHeart FailureDigestive Diseases+6 more
University of Alberta 825
Early research (Phase 1)Ended earlyNCT04311710
What this trial is testing

A Study Evaluating the Drug Levels of Iplimumab Given Under the Skin Alone and in Combination With Nivolumab in Multiple Tumor Types

Who this might be right for
Tumor
Bristol-Myers Squibb 21
Not applicableActive Not RecruitingNCT03179657
What this trial is testing

Guangzhou Nutrition and Health Study (GNHS)

Who this might be right for
Cardiovascular DiseasesOsteoporosisDiabetes Mellitus, Type 2+9 more
Sun Yat-sen University 5,118
Early research (Phase 1)Study completedNCT03849469
What this trial is testing

XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

Who this might be right for
MelanomaCervical CarcinomaPancreatic Carcinoma+20 more
Xencor, Inc. 78
Not applicableLooking for participantsNCT03787056
What this trial is testing

Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients

Who this might be right for
CancerBreast CancerGastric Cancer+14 more
Hospices Civils de Lyon 410
Early research (Phase 1)Study completedNCT00003597
What this trial is testing

Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors

Who this might be right for
Cancer
Children's Oncology Group 16
Not applicableUnknownNCT05081141
What this trial is testing

HHV8 and Solid Organ Transplantation

Who this might be right for
HHV8HHV8 InfectionHHV8-Related Malignant Neoplasm+5 more
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 250
Not applicableStudy completedNCT04072224
What this trial is testing

Evaluation of the Reproducibility of Ablation Volumes at One Month After Microwave Treatment Compared to the Manufacturer's Abacus: on the Kidney, Liver and Lung

Who this might be right for
Hepatic TumorRenal Tumor
Centre Hospitalier Universitaire de Nīmes 60
Testing effectiveness (Phase 2)UnknownNCT03475953
What this trial is testing

A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors

Who this might be right for
Colorectal Cancer Not MSI-H or MMR-deficientGISTOesophageal or Gastric Carcinoma+12 more
Institut Bergonié 747
Not applicableEnded earlyNCT04106167
What this trial is testing

Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy

Who this might be right for
Advanced Solid TumorLymphomaGastric Cancer+15 more
Fate Therapeutics 20
Large-scale testing (Phase 3)Study completedNCT02134899
What this trial is testing

The Efficacy of Everolimus in Reducing Total Native Kidney Volume in Polycystic Kidney Disease Transplanted Recipients

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
Assistance Publique - Hôpitaux de Paris 3
Next Page